Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene
Open Access
- 1 June 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (6), 1259-1261
- https://doi.org/10.1038/bjc.1993.235
Abstract
Loss of heterozygosity (LOH) in tumour cells is generally accepted as 'exposing' recessive cancer genes. The short arm of chromosome 11 shows consistent LOH in Wilms' tumours along its entire length. Occasionally, however, only the 11p13 and/or the 11p15 regions are involved. Deletions of the 11p13 region consistently predisposes to Wilms' tumorigenesis. We have analysed the recently cloned WT1 gene from the 11p13 region exon-by-exon in five tumours previously shown to have undergone LOH for the 11p13 region, using single strand conformation polymorphism analysis (SSCP) and PCR sequencing. Our analysis using SSCP failed to identify any band shifts in the WT1 gene from these tumours. In addition we also sequenced the zinc finger region of WT1, which is the part of the gene most frequently showing mutations. Only the normal sequence was found in all of these tumours. These results demonstrate that LOH in Wilms' tumours is not always related to mutations in the WT1 genes and argues strongly that another gene, probably in the 11p15 region, may be more important in Wilms' tumorigenesis.Keywords
This publication has 25 references indexed in Scilit:
- Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.1992
- Constitutional mutations in the WT1 gene in patients with Denys-Drash syndromeHuman Molecular Genetics, 1992
- Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing.1992
- Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.Proceedings of the National Academy of Sciences, 1992
- Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.1992
- Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.1992
- Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.1991
- Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndromeCell, 1991
- Abnormality of chromosome 11 in patients withfeatures of Beckwith-Wiedemann syndromeThe Journal of Pediatrics, 1983
- A General Theory of CarcinogenesisProceedings of the National Academy of Sciences, 1973